When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the release of toxic granules – ...
Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and a leading cause of cancer mortality. Despite ...
Mid-zone hepatocytes trade proliferation for survival via Atf4-Chop axis in early acute liver injury
This study addresses an important question in liver biology: how zonal hepatocytes balance survival and proliferation following injury; using spatial transcriptomics, mechanistic perturbations, and ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
A deadly fly once wiped out across North America has resurfaced in northern Mexico – and it’s creeping ever closer to the US ...
In a groundbreaking study, scientists have discovered more than 100 new human viruses in 252 different gut microbes, ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...
Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...
Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...
The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback